克拉霉素治疗鼻咽癌放疗后鼻窦炎疗效的Meta分析
作者:
基金项目:

四川省卫生和计划生育科研课题(16PJ221)。


Efficacy of clarithromycin in the treatment of sinusitis after radiotherapy for nasopharyngeal carcinoma: a Meta-analysis study
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的 通过对克拉霉素治疗鼻咽癌(NPC)放疗后鼻窦炎疗效的系统评价,以明确该药的临床应用价值并提供相关循证学证据。方法 检索英文数据库(PubMed、Embase、Cochrane library)及中文数据库(知网、CBM、维普),检索时间为各数据库建库至2020年10月24日,按是否为NPC放疗后鼻窦炎及是否用克拉霉素治疗的标准筛选检索文献后获取相应临床研究资料,使用Review Manager 5.4对纳入的研究进行Meta分析。结果 本文共纳入7篇文献,共516例,研究结果显示克拉霉素对NPC放疗后鼻窦炎的安全性有统计学意义[RR=1.33,95%CI(1.19,1.48),P<0.01],视觉模拟评分法(VSA)具有统计学意义[MD=-2.24,95%CI(-2.51,-1.97),P<0.01]。倒漏斗图分析敏感性较低,提示本研究分析结果较稳定。结论 对于NPC放疗后鼻窦炎的治疗,克拉霉素治疗具有明显的优势且不良反应小,故临床可优先选用克拉霉素。

    Abstract:

    Objective Through the systemic evaluation of the efficacy of clarithromycin in the treatment of sinusitis after radiotherapy for nasopharyngeal carcinoma, to clarify the clinical application value of the drug and provide relevant evidence-based medicine.Methods The english database search (PubMed, Embase, the Cochrane library) and Chinese database (CNKI, CBM, VIP) were retrieved from the establishment of each database to October 24, 2020. According to the criteria of whether it is sinusitis after radiotherapy for nasopharyngeal carcinoma, and whether it is treated with clarithromycin, the relevant clinical research data were obtained after literature screening and retrieval. A meta-analysis study was performed using Review Manager 5.4.Results The reporting studies of seven articles were included in the analysis with a total number of 516 patients. And the results showed that clarithromycin had a statistically significant effect on sinusitis after radiotherapy for nasopharyngeal carcinoma[RR=1.33,95%CI(1.19,1.48),P<0.01], and VSA score was statistically significant [MD=-2.24,95%CI(-2.51,-1.97),P<0.01]. The low sensitivity of the funnel-plot analysis suggested that the analysis results of this study are relatively stable.Conclusion Clarithromycin has obvious advantages and small adverse reactions for the treatment of sinusitis after radiotherapy for nasopharyngeal carcinoma, so the clarithromycin is preferred.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] 邓文霞.鼻咽癌高危人群的识别与干预研究进展[J].世界最新医学信息文摘, 2019, 19(75):26-30.
    [2] 黄春兰, 刘华之, 侯良.鼻咽癌患者放疗常见并发症的预防及护理干预观察[J].中国当代医药, 2017, 24(11):177-179.
    [3] Caponigro F, Longo F, Ionna F, et al. Treatment approaches to nasopharyngeal carcinoma:a review[J]. Anticancer Drugs, 2010, 21(5):471-477.
    [4] Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192):64-80.
    [5] 黄雄超.鼻咽癌放疗后放射性鼻窦炎的研究进展[J].微创医学, 2015, 10(2):195-197.
    [6] 陈伊宁.鼻咽癌放疗后鼻窦炎的临床研究概况[J].广西医学, 2003, 25(7):1163-1166.
    [7] 柯尊斌, 唐荣德, 谭健华, 等.克拉霉素治疗鼻咽癌放疗后鼻窦炎的临床观察[J].临床耳鼻咽喉头颈外科杂志, 2010, 24(7):299-300, 303.
    [8] Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials:is blinding necessary?[J]. Control Clin Trials, 1996, 17(1):1-12.
    [9] 陈翔宇, 张珺祎, 王景丽, 等.克拉霉素治疗鼻咽癌放疗后鼻窦炎的疗效分析[J].中国保健营养, 2016, 26(8):11.
    [10] 郭丽芳.克拉霉素治疗鼻咽癌放疗后鼻窦炎的临床疗效分析[J].世界最新医学信息文摘, 2017, 17(47):79, 81.
    [11] 蒋利华, 周雪宇.克拉霉素治疗鼻咽癌放疗后鼻窦炎的临床观察[J].饮食保健, 2018, 5(15):83-84.
    [12] 米热姑丽·肉孜, 米尔班·祖农, 代红英, 等.克拉霉素治疗鼻咽癌放疗后鼻窦炎的临床观察[J].中国保健营养, 2018, 28(20):86.
    [13] 肖帅, 吴湘玮, 刘雯, 等.克拉霉素治疗鼻咽癌放疗后鼻窦炎的临床效果分析[J].现代养生, 2016, (7):77.
    [14] 闫翠.克拉霉素治疗鼻咽癌放疗后鼻窦炎的临床效果观察[J].临床合理用药杂志, 2019, 12(7):104-105.
    [15] 朱正鹏.克拉霉素治疗鼻咽癌放疗后鼻窦炎的临床观察[J].大家健康, 2017, 11(1):138-139.
    [16] Yuan TZ, Guo X, Zheng L, et al. Occurrence and influencing factors of paranasal sinusitis in nasopharyngeal carcinoma patients after radiotherapy[J]. Ai Zheng, 2008, 27(8):866-869.
    [17] 王继营, 高珊, 崔黎, 等.晚期肿瘤放疗前后免疫功能改变的初步观察[J].肿瘤研究与临床, 2000, 12(5):313-315.
    [18] 陈伊宁.鼻咽癌放疗前后耳鼻咽喉疾病调查分析[J].广西医学, 2003, 25(6):898-901.
    [19] 刘东东.克拉霉素治疗鼻窦炎的临床疗效及其安全性[J].临床合理用药杂志, 2019, 12(24):61-62.
    [20] 杨平, 张伟军.鼻咽癌放疗后鼻窦炎发病机制的研究进展[J].国际医药卫生导报, 2012, 18(9):1363-1365.
    引证文献
引用本文

闫乐,戴林桐.克拉霉素治疗鼻咽癌放疗后鼻窦炎疗效的Meta分析[J].中国耳鼻咽喉颅底外科杂志,2021,27(4):435-439

复制
分享
文章指标
  • 点击次数:88
  • 下载次数: 361
历史
  • 收稿日期:2020-12-10
  • 在线发布日期: 2021-09-02
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭